Myron Holubiak
2016
In 2016, Myron Holubiak earned a total compensation of $432.8K as Chief Executive Officer at Citius Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $112,500 |
---|---|
Option Awards | $95,346 |
Salary | $225,000 |
Total | $432,846 |
Holubiak received $225K in salary, accounting for 52% of the total pay in 2016.
Holubiak also received $112.5K in non-equity incentive plan and $95.3K in option awards.
Rankings
In 2016, Myron Holubiak's compensation ranked 11,669th out of 14,075 executives tracked by ExecPay. In other words, Holubiak earned more than 17.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,669 | 17th |
Manufacturing | 4,555 | 17th |
Chemicals And Allied Products | 1,624 | 14th |
Drugs | 1,314 | 15th |
Pharmaceutical Preparations | 1,019 | 13th |
Holubiak's colleagues
We found two more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2016.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018